| Primary |
| Diabetes Mellitus |
63.0% |
| Diabetes Mellitus Non-insulin-dependent |
11.1% |
| Type 2 Diabetes Mellitus |
11.1% |
| Drug Use For Unknown Indication |
3.7% |
| Hypertension |
3.7% |
| Nephrolithiasis |
3.7% |
| Pain |
3.7% |
|
| Pharmaceutical Product Complaint |
18.9% |
| Blood Glucose Increased |
10.8% |
| Drug Ineffective |
8.1% |
| Medication Error |
8.1% |
| Nausea |
5.4% |
| Pruritus |
5.4% |
| Renal Failure Chronic |
5.4% |
| Vision Blurred |
5.4% |
| Choking |
2.7% |
| Constipation |
2.7% |
| Coombs Direct Test Positive |
2.7% |
| Generalised Erythema |
2.7% |
| Hypersensitivity |
2.7% |
| Hypoglycaemia |
2.7% |
| Lactic Acidosis |
2.7% |
| Metabolic Acidosis |
2.7% |
| No Therapeutic Response |
2.7% |
| Product Quality Issue |
2.7% |
| Product Substitution Issue |
2.7% |
| Renal Failure |
2.7% |
|
| Secondary |
| Diabetes Mellitus |
28.6% |
| Diabetes Mellitus Non-insulin-dependent |
28.6% |
| Drug Use For Unknown Indication |
28.6% |
| Hypertension |
7.1% |
| Type 2 Diabetes Mellitus |
7.1% |
|
| Pruritus Generalised |
53.3% |
| Completed Suicide |
6.7% |
| Obesity |
6.7% |
| Poisoning Deliberate |
6.7% |
| Respiratory Arrest |
6.7% |
| Throat Tightness |
6.7% |
| Weight Decreased |
6.7% |
| Weight Increased |
6.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
17.0% |
| Type 2 Diabetes Mellitus |
13.3% |
| Diabetes Mellitus Non-insulin-dependent |
13.0% |
| Product Used For Unknown Indication |
11.5% |
| Hypertension |
9.3% |
| Diabetes Mellitus |
8.1% |
| Depression |
5.6% |
| Metastases To Bone |
3.0% |
| Blood Cholesterol Increased |
2.7% |
| Breast Cancer |
2.1% |
| Bone Pain |
1.7% |
| Cardiac Disorder |
1.6% |
| Pain |
1.6% |
| Atrial Fibrillation |
1.5% |
| Blood Cholesterol |
1.5% |
| Blood Pressure |
1.4% |
| Neuropathy Peripheral |
1.3% |
| Prophylaxis |
1.3% |
| Constipation |
1.2% |
| Arthritis |
1.1% |
|
| Weight Decreased |
27.6% |
| Blood Glucose Increased |
13.8% |
| Nausea |
9.7% |
| Vomiting |
6.6% |
| Weight Increased |
6.6% |
| Wound Infection Staphylococcal |
4.1% |
| Pancreatitis Acute |
3.6% |
| Flushing |
3.1% |
| Rectal Haemorrhage |
2.6% |
| Tremor |
2.6% |
| Vision Blurred |
2.6% |
| Drug Effect Decreased |
2.0% |
| Fatigue |
2.0% |
| Headache |
2.0% |
| Incorrect Dose Administered |
2.0% |
| Injection Site Haemorrhage |
2.0% |
| Renal Failure |
2.0% |
| Vascular Stenosis |
2.0% |
| Death |
1.5% |
| Drug Ineffective |
1.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
72.7% |
| Cardiac Failure |
18.2% |
| Type 2 Diabetes Mellitus |
9.1% |
|
|
